Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-07-18

Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of a triple combination dorzolamide hydrochloride/brimonidine tartrate/timolol ophthalmic solution for glauco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: WITHDRAWN